Clinical Research Directory

Inclusion Criteria: For Both cohorts: * Participants with aged 15 to 50 years * United States resident * Currently pregnant * Participants personally signed and dated informed consent document or, upon waiver of written consent by the relevant Institutional review board (IRB), verbal consent indicating that the participant (or a legally acceptable representative) has been informed of all pertinent aspects of the study * Authorization and contact information for the reporter (e.g., participant, maternal/infant Health care provider (HCP), prescriber) to allow for follow-up Exposed cohort: • Exposed to gepotidacin at any time during pregnancy or the relevant exposure window Comparator cohort: * Diagnosis of and treatment for uUTI at any time during pregnancy or the relevant comparator product exposure window * Exposed to one or more American College of Obstetricians and Gynecologists (ACOG)-recommended treatments for acute cystitis at any time during pregnancy or the relevant comparator product exposure window Exclusion Criteria: For Both cohorts: • Diagnosis of known MCMs for the index pregnancy prior to enrollment Exposed cohort: • None Comparator cohort: • Exposure to gepotidacin at the time of enrollment